Phase I study of low-dose suramin as a chemosensitizer in Patients with advanced non-small cell lung cancer
- Author
- VILLALONA-CALERO, Miguel A1 2 ; WIENTJES, M. Guillaume1 2 ; SONG, Saeheum1 2 ; GREVER, Michael1 2 ; AU, Jessie L.-S1 2 ; OTTERSON, Gregory A1 2 ; KANTER, Steven1 2 ; YOUNG, Donn1 2 ; MURGO, Anthony J1 2 ; FISCHER, Beth1 2 ; DEHOFF, Carrie1 2 ; CHEN, Danny1 2 ; YEH, Teng-Kuang1 2
[1] Department of Medicine and College of Pharmacy, The Ohio State University, The Arthur G. James Cancer Hospital & Richard J. Solove Research Institute, Columbus, Ohio 43210-1240, United States
[2] The National Cancer Institute, Bethesda, Maryland 20892, United States - Source
Clinical cancer research. 2003, Vol 9, Num 9, pp 3303-3311, 9 p ; ref : 67 ref
- ISSN
- 1078-0432
- Scientific domain
- Medical oncology; Pharmacology drugs
- Publisher
- American Association for Cancer Research, Philadelphia, PA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticancéreux Association médicamenteuse Bronchopulmonaire Carcinome non petite cellule Chimiosensibilisant Chimiothérapie Dose faible Essai clinique phase I Homme Stade avancé Suramine sodique Traitement Tumeur maligne Appareil respiratoire pathologie Bronche pathologie Poumon pathologie
- Keyword (en)
- Antineoplastic agent Drug combination Bronchopulmonary Non small cell carcinoma Chemosensitizing agent Chemotherapy Low dose Phase I trial Human Advanced stage Suramin sodium Treatment Malignant tumor Respiratory disease Bronchus disease Lung disease
- Keyword (es)
- Anticanceroso Asociación medicamentosa Broncopulmonar Carcinoma no pequeña célula Quimiosensibilizante Quimioterapia Dosis débil Ensayo clínico fase I Hombre Estadio avanzado Suramina sódica Tratamiento Tumor maligno Aparato respiratorio patología Bronquio patología Pulmón patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 15106521
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:107:\"Phase I study of low-dose suramin as a chemosensitizer in Patients with advanced non-small cell lung cancer\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Clinical cancer research\";s:9:\"\u0000*\u0000stitle\";s:16:\"Clin. cancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:1:\"9\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"3303\";s:8:\"\u0000*\u0000epage\";s:4:\"3311\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:16:\"VILLALONA-CALERO\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Miguel A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:22:\"WIENTJES, M. Guillaume\";i:1;s:13:\"SONG, Saeheum\";i:2;s:15:\"GREVER, Michael\";i:3;s:15:\"AU, Jessie L.-S\";i:4;s:19:\"OTTERSON, Gregory A\";i:5;s:14:\"KANTER, Steven\";i:6;s:11:\"YOUNG, Donn\";i:7;s:16:\"MURGO, Anthony J\";i:8;s:13:\"FISCHER, Beth\";i:9;s:14:\"DEHOFF, Carrie\";i:10;s:11:\"CHEN, Danny\";i:11;s:15:\"YEH, Teng-Kuang\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:107:\"Phase I study of low-dose suramin as a chemosensitizer in Patients with advanced non-small cell lung cancer\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:107:\"Phase I study of low-dose suramin as a chemosensitizer in Patients with advanced non-small cell lung cancer\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Clinical cancer research\";s:9:\"\u0000*\u0000stitle\";s:16:\"Clin. cancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:1:\"9\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"3303\";s:8:\"\u0000*\u0000epage\";s:4:\"3311\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:16:\"VILLALONA-CALERO\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Miguel A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:22:\"WIENTJES, M. Guillaume\";i:1;s:13:\"SONG, Saeheum\";i:2;s:15:\"GREVER, Michael\";i:3;s:15:\"AU, Jessie L.-S\";i:4;s:19:\"OTTERSON, Gregory A\";i:5;s:14:\"KANTER, Steven\";i:6;s:11:\"YOUNG, Donn\";i:7;s:16:\"MURGO, Anthony J\";i:8;s:13:\"FISCHER, Beth\";i:9;s:14:\"DEHOFF, Carrie\";i:10;s:11:\"CHEN, Danny\";i:11;s:15:\"YEH, Teng-Kuang\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:107:\"Phase I study of low-dose suramin as a chemosensitizer in Patients with advanced non-small cell lung cancer\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:107:\"Phase I study of low-dose suramin as a chemosensitizer in Patients with advanced non-small cell lung cancer\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Clinical cancer research\";s:9:\"\u0000*\u0000stitle\";s:16:\"Clin. cancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:1:\"9\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"3303\";s:8:\"\u0000*\u0000epage\";s:4:\"3311\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:16:\"VILLALONA-CALERO\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Miguel A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:22:\"WIENTJES, M. Guillaume\";i:1;s:13:\"SONG, Saeheum\";i:2;s:15:\"GREVER, Michael\";i:3;s:15:\"AU, Jessie L.-S\";i:4;s:19:\"OTTERSON, Gregory A\";i:5;s:14:\"KANTER, Steven\";i:6;s:11:\"YOUNG, Donn\";i:7;s:16:\"MURGO, Anthony J\";i:8;s:13:\"FISCHER, Beth\";i:9;s:14:\"DEHOFF, Carrie\";i:10;s:11:\"CHEN, Danny\";i:11;s:15:\"YEH, Teng-Kuang\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:107:\"Phase I study of low-dose suramin as a chemosensitizer in Patients with advanced non-small cell lung cancer\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:107:\"Phase I study of low-dose suramin as a chemosensitizer in Patients with advanced non-small cell lung cancer\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Clinical cancer research\";s:9:\"\u0000*\u0000stitle\";s:16:\"Clin. cancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:1:\"9\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"3303\";s:8:\"\u0000*\u0000epage\";s:4:\"3311\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:16:\"VILLALONA-CALERO\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Miguel A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:22:\"WIENTJES, M. Guillaume\";i:1;s:13:\"SONG, Saeheum\";i:2;s:15:\"GREVER, Michael\";i:3;s:15:\"AU, Jessie L.-S\";i:4;s:19:\"OTTERSON, Gregory A\";i:5;s:14:\"KANTER, Steven\";i:6;s:11:\"YOUNG, Donn\";i:7;s:16:\"MURGO, Anthony J\";i:8;s:13:\"FISCHER, Beth\";i:9;s:14:\"DEHOFF, Carrie\";i:10;s:11:\"CHEN, Danny\";i:11;s:15:\"YEH, Teng-Kuang\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:107:\"Phase I study of low-dose suramin as a chemosensitizer in Patients with advanced non-small cell lung cancer\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:107:\"Phase I study of low-dose suramin as a chemosensitizer in Patients with advanced non-small cell lung cancer\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Clinical cancer research\";s:9:\"\u0000*\u0000stitle\";s:16:\"Clin. cancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:1:\"9\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"3303\";s:8:\"\u0000*\u0000epage\";s:4:\"3311\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:16:\"VILLALONA-CALERO\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Miguel A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:22:\"WIENTJES, M. Guillaume\";i:1;s:13:\"SONG, Saeheum\";i:2;s:15:\"GREVER, Michael\";i:3;s:15:\"AU, Jessie L.-S\";i:4;s:19:\"OTTERSON, Gregory A\";i:5;s:14:\"KANTER, Steven\";i:6;s:11:\"YOUNG, Donn\";i:7;s:16:\"MURGO, Anthony J\";i:8;s:13:\"FISCHER, Beth\";i:9;s:14:\"DEHOFF, Carrie\";i:10;s:11:\"CHEN, Danny\";i:11;s:15:\"YEH, Teng-Kuang\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:107:\"Phase I study of low-dose suramin as a chemosensitizer in Patients with advanced non-small cell lung cancer\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
